Search clinical trials for: ruxolinib refractory

Total 9071 results

Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell Transplant

Cancer

United States
Wolfson Medical Center

Unknown

Combined Treatment With Fresh Frozen Plasma and Rituximab (Mabthera) in Patients With Advanced Refractory Chronic Lymphocytic Leukemia

Advanced Refractory Chronic Lymphocytic Leukemia

Israel
Dendreon

Completed

Immunotherapy With APC8015 (Sipuleucel-T, Provenge) for Asymptomatic, Metastatic, Hormone-Refractory Prostate Cancer

Hormone-Refractory Prostate Cancer
Dendreon

Completed

Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy

Prostate Cancer

United States, Canada
Istituto Clinico Humanitas

Completed

A Phase II Study of IGEV +/- Bortezomib Before Hign Dose Consolidation in Relapsed/Refractory Hodgkin's Lymphoma

Hodgkin Disease

Italy
Hospital Universitario Dr. Jose E. Gonzalez

Completed

Alemtuzumab and Rituximab in the Treatment of Refractory Autoimmune Cytopenias

Idiopathic Thrombocytopenic Purpura | Anemia, Hemolytic, Autoimmune

Mexico
MedtronicNeuro

Terminated

Neurostimulation to Treat Refractory Angina Pectoris Pain (STARTSTIM)

Angina Pectoris

United States, Canada
Ascenta Therapeutics

Completed

A Randomized Phase 2 Study of AT-101 in Combination With Docetaxel in Relapsed/Refractory Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer

Russian Federation, United States, Ukraine
Ascenta Therapeutics

Completed

Study of AT-101 in Combination With Topotecan in Relapsed/Refractory Small Cell Lung Cancer

Small Cell Lung Cancer

United States, Russian Federation, Ukraine
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Biological Therapy After Chemotherapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Lymphoma | Leukemia

United States
Ascenta Therapeutics

Completed

A Study of Single-Agent AT-101 in Men With Hormone Refractory Prostate Cancer

Hormone Refractory Prostate Cancer

United States
Medical University of Vienna

Unknown

Biomarker Study for Sunitinib and Docetaxel in Prostate Cancer

Hormone Refractory Prostate Cancer

Austria
University of Ulm

Completed

Gemtuzumab Ozogamicin in Combination With A-HAM in Refractory AML (GO-A-HAM)

Leukemia, Myeloid, Acute

Germany, Austria
Hospital de Clinicas de Porto Alegre

Completed

A Pilot Double-blind Sham-controlled Trial of Repetitive Transcranial Magnetic Stimulation for Patients With Refractory Schizophrenia Treated With Clozapine

Schizophrenia | Auditory Hallucinations

Brazil
Samsung Medical Center
National Cancer Center, Korea

Completed

Autologous Dendritic Cell Therapy for Hormone-Refractory Metastatic Prostate Cancer

Prostatic Cancer

Korea, Republic of
Case Comprehensive Cancer Center

Completed

High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma

Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent... and other conditions

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

UCN-01 in Treating Patients With Advanced Cancer

Lymphoma | Leukemia | Unspecified Adult Solid Tumor, Protocol Specific

United States
British Columbia Cancer Agency

Completed

A Study of BAY 43-9006 in Combination With Bicalutamide in Patients With Chemo-Naïve Hormone Refractory Prostate Cancer

Adenocarcinoma of the Prostate

Canada
SCRI Development Innovations, LLC
Bristol-Myers Squibb

Completed

Weekly Paclitaxel, Low-Dose Estramustine, and Carboplatin in the Treatment of Hormone Refractory Prostate Carcinoma

Prostate Cancer
University of Arkansas

Completed

Study of Combination PS-341 and Thalidomide in Multiple Myeloma

Multiple Myeloma

United States
SCRI Development Innovations, LLC
Millennium Pharmaceuticals, Inc.; Aventis Pharmaceuticals

Completed

Weekly Docetaxel and Bortezomib in the Treatment of Advanced Hormone-Refractory Prostate Cancer

Prostate Cancer
AGO Study Group

Completed

A Phase II Study of ZD1839 and Tamoxifen in Patients With Epithelial Ovarian Carcinoma, Cancer of the Fallopian Tube or the Peritoneum Refractory to Platinum- and Taxane-based Therapy

Ovarian Cancer | Peritoneal Cancer | Cancer of the Fallopian Tube

Germany
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Etanercept for the Treatment of Refractory Heel Enthesitis in Spondylarthropathy

Spondylarthropathies, Enthesitis

France, Germany, Netherlands
Cooperative Study Group A for Hematology

Unknown

Efficacy of Helicobacter Pylori Eradication, Anti-D and Danazol Combination in Steroid Dependant or Refractory Immune Thrombocytopenia (ITP)

Thrombocytopenia

Korea, Republic of
University of California, Irvine

Completed

Combined Anticholinergic Medication and Sacral Neuromodulation to Treat Refractory Overactive Bladder

Overactive Bladder

United States
Takeda

Completed

Efficacy Study of Pioglitazone and Atorvastatin Combination Therapy in Treating Subjects With Elevated Risk for Cardiovascular Disease

Cardiovascular Diseases
University of Arkansas

Completed

Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide

Multiple Myeloma

United States
University of Arkansas
Celgene Corporation

Completed

Thalidomide Anti-Angiogenesis Therapy of Relapsed or Refractory Leukemia

Leukemia

United States
University of Arkansas

Completed

An Open Protocol for the Compassionate Use of Thalidomide

Multiple Myeloma

United States
SCRI Development Innovations, LLC
Millennium Pharmaceuticals, Inc.

Completed

Weekly Bortezomib (Velcade) in the Treatment of Patients With Refractory Multiple Myeloma

Multiple Myeloma

United States
University of Zurich

Completed

Intravesical Injection of Botox for Treating Therapy Refractory Overactive Bladder in Females

Overactive Bladder Syndrome

Switzerland
MedImmune LLC

Completed

BL22 Immunotoxin in Treating Patients With Refractory Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, or Non-Hodgkin's Lymphoma

Lymphoma | Leukemia

United States
MedImmune LLC

Completed

BL22 Immunotoxin in Treating Patients Previously Treated With Cladribine for Hairy Cell Leukemia

Leukemia

United States
European Organisation for Research and Treatment...

Completed

Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome

Myelodysplastic Syndromes | Leukemia

France, Belgium, Portugal
Fred Hutchinson Cancer Center

Completed

Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation

Cancer

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Campath-1H + FK506 and Methylprednisolone for GVHD

Lymphoma | Myelodysplastic Syndromes | Leukemia | Testicular Germ Cell Tumor | Breast Cancer | Chronic Myeloproliferative Disorders | Ovarian Cancer | Gestational Trophoblastic Tumor | Neuroblastoma | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Diseases | Graft Versus Host...

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia

Leukemia

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia or Lymphoma

Lymphoma | Leukemia

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Cancer

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

O6-benzylguanine And Carmustine in Treating Patients With Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Fludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed/Refractory Acute Leukemia or Advanced Myelodysplastic Syndrome

Myelodysplastic Syndromes | Leukemia

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Lymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Diseases

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Pilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic Conditions

Myelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative Diseases

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Fludarabine/Carboplatin/Topotecan w/Thalidomide for Relapsed/Refractory AML, CML and MDS

Myelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative Diseases

United States
Kaplan Medical Center
Gilead Sciences

Unknown

The Humanized Monoclonal Antibody Milatuzumab for Refractory Chronic Lymphocytic Leukemia (CLL)

Chronic Lymphocytic Leukemia

Israel
Florida Academic Dermatology Centers
Celgene Corporation

Unknown

Open-label Pilot Study of Lenalidomide (Revlimid) as Adjuvant Treatment for Refractory Cutaneous T Cell Lymphoma (REvMM2009)

Cutaneous T Cell Lymphoma

United States
European Organisation for Research and Treatment...

Unknown

Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia

Myelodysplastic Syndromes | Leukemia

Switzerland, Netherlands, France, Belgium, Germany, Sweden, Croatia, Czech Republic, Italy
Fudan University

Suspended

Combination of Capecitabine and Oxaliplatin in Patients With Relapsed or Refractory Gastric Cancer

Gastric Cancer

China
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Pharmacokinetics, Safety and Tolerability of Topiramate in Infants (Age 1-24 Months) With Refractory Partial-onset Seizures

Seizures
Vanak Eye Surgery Center

Unknown

Ahmed Valve Glaucoma Implant With Adjunctive Subconjunctival Bevacizumab in Refractory Glaucoma

Refractory Glaucoma

Iran, Islamic Republic of

Search clinical trials for: ruxolinib refractory

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovakia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations